Dr. Frank P Cammisa Jr. is a New York, New York based male orthopedic surgeon who is specialized in Orthopaedic Surgery of the Spine. Active license number of Dr. Frank P Cammisa Jr. is 170322 for Orthopaedic Surgery of the Spine in New York.
Dr. Frank P Cammisa Jr. deals with the evaluation and nonoperative and operative treatment of the full spectrum of primary spinal disorders including trauma, degenerative, deformity, tumor, and reconstructive.
Complete Profile:
Dr. Frank P Cammisa Jr. speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Orthopedic - Orthopaedic Surgery of the Spine
Credentials:
M.D.
Gender:
Male
Practice Address:
523 E 72nd St, New York, New York, 10021-4099
Phone:
212-606-1946
Fax:
212-472-1486
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1275588246
NPI Enumeration Date:
24 May, 2006
NPI Last Update On:
24 Mar, 2021
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Frank P Cammisa Jr. are as mentioned below.
License Number
Specialization
State
Status
170322
Orthopaedic Surgery of the Spine
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
523 E 72nd St, New York, New York
Zip:
10021-4099
Phone Number:
212-606-1946
Fax Number:
212-472-1486
Patients can reach Dr. Frank P Cammisa Jr. at 523 E 72nd St, New York, New York or can call to book an appointment on 212-606-1946. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.